Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.140
-0.060 (-2.73%)
At close: Jul 10, 2026, 4:00 PM EDT
2.150
+0.010 (0.47%)
After-hours: Jul 10, 2026, 6:01 PM EDT
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $32.09 million as of July 10, 2026. Its market cap has decreased by -45.61% in one year.
Market Cap
32.09M
Enterprise Value
10.76M
1-Year Change
-45.61%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $32.09M, a decrease of -74.35%. That is a compound annual growth rate of -44.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 32.09M | 57.32% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 36.10M |
| NanoViricides | 34.17M |
| Lite Strategy | 33.91M |
| Tvardi Therapeutics | 32.08M |
| BriaCell Therapeutics | 31.75M |
| Senti Biosciences Holdings | 31.46M |
| Kyntra Bio | 30.36M |
| Daré Bioscience | 30.26M |